Why the study?
Does ivabradine reduce chemokine-induced migration in CD4-positive lymphocytes?
Does ivabradine reduce chemokine-induced migration in CD4-positive lymphocytes?
Ivabradine inhibits chemokine-induced migration of CD4-positive lymphocytes via the PI-3 kinase pathway, suggesting a potential mechanism for its anti-atherosclerotic effects.
No takes yet. Share an insight, caveat, or question.
May attenuate CD4+ lymphocyte migration in vitro; hypothesis-generating for anti-atherosclerotic effects, untested in humans.
Walcher et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: